Singapore markets close in 7 hours

Straits Times Index
3,123.39
-6.85(-0.22%)
Nikkei
25,977.07
+39.86(+0.15%)
Hang Seng
17,182.38
-40.45(-0.23%)
FTSE 100
6,893.81
+12.22(+0.18%)
BTC-USD
19,227.94
-76.58(-0.40%)
CMC Crypto 200
437.26
-6.17(-1.39%)

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

1.1900

+0.0300

(+2.59%)

At close: 04:00PM EDT

1.1800

-0.01

(-0.84%)

After hours:

07:53PM EDT

Loading interactive chart…

Business Wire
Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement
BOULDER, Colo. & PETACH TIKVA, Israel, September 21, 2022--Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement
Zacks
Clovis (CLVS) Seeks Nod for Rubraca in First Line Ovarian Cancer
Clovis (CLVS) files regulatory applications in the United States and Europe seeking label expansion for its sole marketed drug as a first-line maintenance treatment in advanced ovarian cancer.
Business Wire
Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer
BOULDER, Colo., September 13, 2022--Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with AOC